Get the Stockscreener App
0.291
6.67%
-0.0208
Pre-market:
.30
0.009
+3.09%
Tivic Health Systems Inc stock is traded at $0.291, with a volume of 373.68K.
It is down -6.67% in the last 24 hours and up +11.92% over the past month.
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
See More
Previous Close:
$0.3118
Open:
$0.3108
24h Volume:
373.68K
Relative Volume:
0.06
Market Cap:
$2.75M
Revenue:
$957.00K
Net Income/Loss:
$-6.42M
P/E Ratio:
-0.0942
EPS:
-3.0899
Net Cash Flow:
$-6.13M
1W Performance:
-15.16%
1M Performance:
+11.92%
6M Performance:
-15.55%
1Y Performance:
-83.56%
1-Day Range:
$0.28
$0.3118
1-Week Range:
$0.28
$0.365
52-Week Range:
$0.201
$2.24
Tivic Health Systems Inc Stock (TIVC) Company Profile
Name
Tivic Health Systems Inc
Sector
Industry
Phone
(888)276-6888
Address
47685 LAKEVIEW BLVD, FREMONT
Compare TIVC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIVC
Tivic Health Systems Inc
|
0.291 | 2.75M | 957.00K | -6.42M | -6.13M | -3.0899 |
|
ABT
Abbott Laboratories
|
114.25 | 198.16B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.95 | 141.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
364.10 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
82.68 | 106.02B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.15 | 43.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Tivic Health Systems Inc Stock (TIVC) Latest News
Enrollment Complete in Tivic Health’s VNS Device Trial - MPO-mag
Tivic Health faces potential Nasdaq delisting By Investing.com - Investing.com Australia
Tivic Health faces potential Nasdaq delisting - Investing.com
Tivic Health Validates European Patents - MPO-mag
Analyzing QT Imaging (NASDAQ:QTI) & Tivic Health Systems (NASDAQ:TIVC) - Defense World
Tivic Health Systems Issues CEO Letter Highlighting Progress and Future Plans - Defense World
US Stocks To Open Higher On Shortened Trading Day: Santa Claus Rally Period Officially Begins, Says Analyst - Benzinga
TIVCTivic Health Systems, Inc. Latest Stock News & Market Updates - StockTitan
CEO Letter to Shareholders Issued by Tivic Health - Lelezard
Tivic Health Doubles Margins, Eyes $21B VNS Market with Breakthrough Technology - StockTitan
What Did We Note About Insider Trading At Tivic Health Systems Inc (NASDAQ: TIVC)? - Stocks Register
Tivic Health stock plunges to 52-week low of $0.22 By Investing.com - Investing.com Canada
Tivic Health stock plunges to 52-week low of $0.22 - Investing.com India
Tivic Health Kicks Off Vagus Nerve Stimulation Device Trial - MPO-mag
Tivic Health Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Tivic Health Systems Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$1.48 loss in 3Q 2023) - Yahoo Finance
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q3 2024 Earnings Call Transcript - Insider Monkey
Tivic Health Q3: 70% Gross Margins Achieved Despite Revenue Drop; Net Loss Narrows | TIVC Stock News - StockTitan
Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update - The Bakersfield Californian
Tivic Health Systems Reports Third Quarter 2024 Results - TipRanks
Tivic Health Systems Inc. (TIVC) Quarterly 10-Q Report - Quartzy
Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device - The Bakersfield Californian
Tivic Health Validates European Patents in Great Britain, Germany, and France - Marketscreener.com
Tivic Health Secures Key European Patents for ClearUP Sinus Treatment Technology | TIVC Stock News - StockTitan
U.S. Stock market: FOXO Technologies(+134.66%) Northann Corp.(+67.38%) and ProPhase Labs(-47.43%) were the most volatile stocks during midday trading - Business Upturn
U.S. Stock market: Tivic Health up 138.62%, Northann surges 120.19%, ProPhase Labs down 50.70% among the most volatile stocks during early trading - Business Upturn
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14 - Business Wire
First Subject Enrolled in Tivic Health’s Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device - The Bakersfield Californian
Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024 - Business Wire
Tivic Health's Non-Invasive Cervical Vagus Nerve Stimulation Approach Wins Study Approval - MPO-mag
Market Resilience: Tivic Health Systems Inc (TIVC) Finishes Weak at 0.23, Down -10.00 - The Dwinnex
A stock that deserves closer examination: Tivic Health Systems Inc (TIVC) - US Post News
What's Going On With Tivic Health Stock? - MSN
Tivic Health stock hits 52-week low at $0.23 amid market challenges - Investing.com
Tivic Health Systems Inc (TIVC) Stock: A Year of Market Fluctuations - The InvestChronicle
Tivic Health Systems Inc [TIVC] Stock trading around $0.26 per share: What’s Next? - The DBT News
Lisa Wolf Named Interim CFO at Tivic Health - MPO-mag
electroCore (NASDAQ:ECOR) vs. Tivic Health Systems (NASDAQ:TIVC) Critical Survey - Defense World
There is no way Tivic Health Systems Inc (TIVC) can keep these numbers up - SETE News
Tivic Health advances in non-invasive nerve stimulation - Investing.com
Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment - Business Wire
Balance Sheet Breakdown: Tivic Health Systems Inc (TIVC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Tivic Health partners with Fletcher Spaght for growth strategy - Investing.com
Tivic Health partners with Fletcher Spaght for growth strategy By Investing.com - Investing.com UK
Tivic Health Accelerates VNS Commercial Strategy Development - Business Wire
Tivic Health Appoints Lisa Wolf As Interim Chief Financial Officer - citybiz
Tivic Health names Lisa Wolf as interim CFO - MSN
Tivic Health names Lisa Wolf as Interim CFO - TipRanks
Tivic Health Names Wolf Interim CFO - MarketWatch
Tivic Health Systems Initiates Stock Sale and Leadership Transition - TipRanks
Tivic Health Systems Inc Stock (TIVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):